Pregnancy risks and precautions while taking avatrombopag (Sucoxin)
Avatrombopag (Avatrombopag) is an oral thrombopoietic drug mainly used to treat diseases such as thrombocytopenia or aplastic anemia associated with chronic liver disease. The safety of this drug when used during pregnancy has not been fully demonstrated in large-scale clinical trials, so pregnant women and women planning pregnancy should use special caution. Drugs may pose potential risks to the mother and fetus by affecting platelet production and blood system function.
There are currently data showing that avatrombopag may have certain effects on the fetus in animal experiments, such as changes in placental blood flow or abnormal platelet levels, but there is insufficient human data to support its safety during pregnancy. Therefore, the use of this drug during pregnancy needs to be done under strict medical evaluation and only considered when the potential benefits clearly outweigh the risks. Doctors generally recommend avoiding use before or during pregnancy to reduce potential harm to the fetus.
For women who are taking avatrombopag and plan to become pregnant, it is recommended to fully communicate with their doctor and adjust the treatment plan if necessary or switch to an alternative drug with a clearer safety profile. At the same time, women should take reliable contraceptive measures during treatment until the doctor confirms that the blood drug concentration has dropped to a safe range after stopping the drug before considering pregnancy plans. For patients with unintended pregnancy, they should inform their doctor immediately to assess the risks of medication and develop a monitoring plan.
In general, there are potential risks when using avatrombopag during pregnancy. Therefore, pregnant women and women planning pregnancy need to strictly follow the doctor's instructions and avoid self-medication or dosage adjustment. The medical team will conduct an individualized assessment based on the patient's condition, platelet level and treatment necessity, and provide contraceptive advice, medication alternatives and pregnancy monitoring measures to maximize the safety of the mother and fetus.
Reference materials:https://www.drugs.com/
[ 免责声明 ] 本页面内容来自公开渠道(如FDA官网、Drugs官网、原研药厂官网等),仅供持有医疗专业资质的人员用于医学药学研究参考,不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市,不适用于中国境内销售和使用。如需治疗,请咨询正规医疗机构。本站不提供药品销售或代购服务。
.jpeg)